WallStSmart

Airsculpt Technologies Inc (AIRS)vsUniversal Health Services Inc (UHS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Universal Health Services Inc generates 11597% more annual revenue ($17.76B vs $151.84M). UHS leads profitability with a 8.6% profit margin vs -7.4%. UHS earns a higher WallStSmart Score of 70/100 (B).

AIRS

Avoid

34

out of 100

Grade: F

Growth: 5.3Profit: 2.0Value: 5.3Quality: 3.5
Piotroski: 2/9Altman Z: 0.75

UHS

Strong Buy

70

out of 100

Grade: B

Growth: 6.7Profit: 7.0Value: 6.0Quality: 6.0
Piotroski: 5/9Altman Z: 2.76
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AIRSUndervalued (+11.7%)

Margin of Safety

+11.7%

Fair Value

$2.40

Current Price

$5.11

$2.71 discount

UndervaluedFair: $2.40Overvalued
UHSSignificantly Overvalued (-29.7%)

Margin of Safety

-29.7%

Fair Value

$178.30

Current Price

$145.17

$33.13 premium

UndervaluedFair: $178.30Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AIRS1 strengths · Avg: 10.0/10
EPS GrowthGrowth
200.0%10/10

Earnings expanding 200.0% YoY

UHS3 strengths · Avg: 9.7/10
P/E RatioValuation
6.1x10/10

Attractively priced relative to earnings

Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Return on EquityProfitability
20.2%9/10

Every $100 of equity generates 20 in profit

Areas to Watch

AIRS4 concerns · Avg: 3.0/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

Market CapQuality
$382.36M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-11.2%2/10

ROE of -11.2% — below average capital efficiency

UHS0 concerns · Avg: 0/10

No major concerns identified

Comparative Analysis Report

WallStSmart Research

Bull Case : AIRS

The strongest argument for AIRS centers on EPS Growth.

Bull Case : UHS

The strongest argument for UHS centers on P/E Ratio, Price/Book, Return on Equity. PEG of 1.02 suggests the stock is reasonably priced for its growth.

Bear Case : AIRS

The primary concerns for AIRS are Revenue Growth, Market Cap, Piotroski F-Score.

Bear Case : UHS

No major red flags identified for UHS, but monitor valuation.

Key Dynamics to Monitor

AIRS profiles as a turnaround stock while UHS is a value play — different risk/reward profiles.

AIRS carries more volatility with a beta of 2.02 — expect wider price swings.

UHS is growing revenue faster at 9.6% — sustainability is the question.

UHS generates stronger free cash flow (184M), providing more financial flexibility.

Bottom Line

UHS scores higher overall (70/100 vs 34/100). Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Airsculpt Technologies Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Airsculpt Technologies Inc (AIRS) is a pioneering company in the aesthetic medical technology sector, renowned for its innovative AirSculpt® procedure that delivers minimally invasive body contouring with a strong commitment to patient safety and comfort. The company is strategically expanding its network of licensed practitioners, supported by a robust focus on technological advancements, which positions Airsculpt favorably within the rapidly growing non-invasive cosmetic treatment market. As consumer demand for aesthetic solutions continues to rise globally, Airsculpt is well-positioned to enhance its market share and diversify its service offerings, aiming to achieve substantial growth and sustainable value for its investors.

Visit Website →

Universal Health Services Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

UnitedHealth Group Incorporated is an American for-profit multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services.

Visit Website →

Want to dig deeper into these stocks?